PharmaBoardroom

Politics & Markets: The Role of the Private Sector in…

Brendan Shaw outlines the long road still to travel to meet the UN Sustainable Development goal of ensuring basic healthcare financing for every…

Janet Woodcock – Director, Center for Drug Evaluation and…

In an exclusive interview, Janet Woodcock, head of the Center for Drug Evaluation and Research (CDER) at the US Food & Drug Administration (FDA)…

Mexican Healthcare Reforms: Question Marks Remain

The election of populist President Andres Manuel Lopez Obrador (AMLO) on 1 July 2018 heralded a new era of hope and optimism for Mexicans. In the…

The UAE: Early Adopters of Cutting-Edge Medical Technology

In some respects, is it perhaps the medtech sector that has most to be excited about in the UAE’s domestic market, given the country’s unrelenting…

Embracing Innovation: The UAE as an Initial Product Launch…

The UAE’s distinctive willingness to embrace innovation and the ‘can-do’ spirit of authorities marks the country out as worthy of attention as…

Colombian Tecnoquimicas’ USD 200 Million Manufacturing…

Tecnoquimicas (TQ), the largest domestic player in Colombia’s USD 4.6 billion pharma market, announced a swathe of manufacturing investments in late…

German Pharma News Roundup: February 2020

Some of the top recent stories from Germany, Europe's leading pharma market according to CPhI, including big new investments from Merck and Bayer, the…

Humaid Al Qutami – Director General, Dubai Health Authority

The Dubai Health Authority, the government body responsible for overseeing Dubai’s health system, is working full speed as the 2021 mark laid by the…

Juan de Villafranca – Executive Director, AMELAF, Mexico

Juan de Villafranca, executive director of the Asociacion Mexicana de Laboratorios Farmaceuticos (AMELAF), shares the exciting new initiatives he has…